Jaundice
Yellowing of skin, sclera, and mucous membranes due to elevated serum bilirubin.
Jaundice, also known as icterus, is a clinical sign characterized by yellow pigmentation of the skin, sclerae (whites of the eyes), and mucous membranes due to elevated levels of bilirubin in the blood (hyperbilirubinemia). It becomes clinically detectable when the serum bilirubin level exceeds approximately 40-50 µmol/L (2-3 mg/dL). It is not a disease itself but a symptom of an underlying disorder in bilirubin metabolism, transport, or excretion.
Key Concept
The term "jaundice" comes from the French word "jaune," meaning yellow. The sclera is often the first place to notice jaundice because it has a high affinity for bilirubin due to its high elastin content.
The epidemiology of jaundice is entirely dependent on its underlying cause. However, some patterns are important:
- Age: Neonatal jaundice is extremely common (affecting ~60% of term infants). In adults, the causes shift. Malignant biliary obstruction (e.g., pancreatic cancer, cholangiocarcinoma) is more common in the elderly, while gallstone disease peaks in middle age.
- Geography/Hong Kong Context: Certain etiologies have a higher prevalence in Asia and Hong Kong:
- Hepatitis B Virus (HBV) Infection: Hong Kong has an intermediate endemicity. Chronic HBV is a leading cause of cirrhosis and hepatocellular carcinoma (HCC), both of which can present with jaundice.
- Recurrent Pyogenic Cholangitis (RPC): Known historically as "Hong Kong disease." Associated with intrahepatic pigment stone formation and parasitic infections (e.g., Clonorchis sinensis from raw freshwater fish).
- Cholangiocarcinoma: Higher incidence in regions with endemic liver fluke infestation and RPC.
- General Risk Factors:
- Gallstones: Female gender, obesity, rapid weight loss, pregnancy (the "4 F's" - Female, Fat, Forty, Fertile - is an outdated but classic mnemonic).
- Alcoholic Liver Disease: Chronic heavy alcohol use.
- Medications: Many drugs can cause hepatocellular injury or cholestasis (e.g., antibiotics, NSAIDs, anticonvulsants).
- Genetic Disorders: Gilbert's syndrome (very common, ~5-10% of population), Crigler-Najjar, Dubin-Johnson syndromes.
Understanding the biliary tree's anatomy is crucial for localizing the cause of obstructive jaundice.
Key Anatomical Points:
- Bile Production: Hepatocytes continuously produce bile, which is modified by ductal cells.
- Gallbladder Function: Stores and concentrates bile by absorbing water and electrolytes. Contracts in response to cholecystokinin (CCK) after a meal, ejecting bile.
- Sphincter of Oddi: A smooth muscle valve that controls the flow of bile and pancreatic juice into the duodenum and prevents duodenal contents from refluxing back.
- Blood Supply: The liver has a dual supply: the hepatic artery (25% of flow, 50% of oxygen) and the portal vein (75% of flow, 50% of oxygen). The bile ducts are supplied by the hepatic artery, making them vulnerable to ischemic injury.
To understand jaundice, you must know bilirubin metabolism inside out. This is a classic exam topic.
Step 1: Production (Pre-hepatic Phase)
- Source: 80-85% comes from the breakdown of senescent red blood cells (RBCs) in the spleen, liver, and bone marrow. The heme portion of hemoglobin is the precursor.
- Process: Macrophages break down heme into iron (recycled), carbon monoxide (exhaled), and biliverdin (green pigment). Biliverdin is rapidly converted to unconjugated bilirubin (UCB).
- Characteristics of UCB: It is lipid-soluble, insoluble in water, and tightly bound to albumin in the blood. It cannot be excreted in urine.
Step 2: Hepatic Uptake & Conjugation (Hepatic Phase)
- Uptake: UCB-albumin complex travels to the liver. UCB dissociates and is taken up by hepatocytes via specific transporters.
- Conjugation: Inside the hepatocyte, UCB is conjugated with glucuronic acid by the enzyme UDP-glucuronosyltransferase (UGT1A1) to form conjugated bilirubin (CB).
- Characteristics of CB: It is water-soluble, non-toxic, and can be excreted.
Step 3: Excretion & Enterohepatic Circulation (Post-hepatic Phase)
- Excretion: CB is actively secreted into bile canaliculi and flows down the biliary tree into the duodenum.
- Intestinal Fate: In the colon, bacteria deconjugate CB and convert it into urobilinogen.
- Most urobilinogen is oxidized to stercobilin (brown pigment) and excreted in stool.
- About 20% is reabsorbed into the portal circulation (enterohepatic circulation).
- Renal Fate: The reabsorbed urobilinogen is mostly re-excreted by the liver. A small amount (~2%) is excreted by the kidneys, giving urine its yellow color.
High Yield Summary - Bilirubin Pathways
- Unconjugated = Indirect = Lipid-soluble = Albumin-bound = NOT in urine.
- Conjugated = Direct = Water-soluble = NOT albumin-bound = CAN be in urine (bilirubinuria).
- Urobilinogen in urine comes from reabsorbed intestinal urobilinogen. Its absence suggests complete biliary obstruction.
Etiology and Pathophysiology
Jaundice is classified based on which step in bilirubin metabolism is disrupted. The three main categories are pre-hepatic, hepatic (hepatocellular), and post-hepatic (obstructive/cholestatic).
- Pathophysiology: Excessive production of bilirubin overwhelms the liver's normal capacity to conjugate and excrete it. The liver is normal but cannot keep up.
- Key Etiologies:
- Hemolysis: Breakdown of RBCs. Causes include autoimmune hemolytic anemia, G6PD deficiency, sickle cell crisis, malaria, prosthetic heart valves.
- Ineffective Erythropoiesis: Seen in megaloblastic anemias (B12/folate deficiency), thalassemia.
- Large Hematoma Resorption: After major trauma or surgery.
- Hong Kong Relevance: G6PD deficiency is relatively common in Southern Chinese males.
- Pathophysiology: Dysfunction of the hepatocytes themselves. This impairs all three hepatic steps: uptake, conjugation, and excretion. Therefore, you see a mixed picture with elevations of both unconjugated and conjugated bilirubin, but often with a predominance of conjugated because excretion is the rate-limiting step.
- Key Etiologies:
- Viral Hepatitis: Hepatitis A, B, C, D, E. HBV is a major cause in HK.
- Alcoholic Liver Disease: From fatty liver to hepatitis to cirrhosis.
- Non-Alcoholic Fatty Liver Disease (NAFLD)/NASH: Increasingly common with the obesity epidemic.
- Cirrhosis (any cause): End-stage of chronic liver disease. In HK, HBV is the most common cause of cirrhosis [1].
- Drug-Induced Liver Injury (DILI): A huge list (e.g., paracetamol overdose, antibiotics, antituberculous drugs).
- Autoimmune Hepatitis.
- Genetic Disorders: Wilson's disease, hemochromatosis, alpha-1 antitrypsin deficiency.
- Ischemic Hepatitis ("Shock Liver").
- Pathophysiology: Mechanical obstruction of the biliary tree prevents the flow of conjugated bilirubin from the liver to the intestine. Pressure builds up, causing bile to "back up" into the liver and leak into the bloodstream (cholemia). Conjugated bilirubin is water-soluble and appears in the urine.
- Key Etiologies (Use Anatomical Level):
- Intraluminal: Choledocholithiasis (CBD stone) - the most common cause of painful obstructive jaundice.
- Mural (Wall of the duct):
- Malignant: Cholangiocarcinoma (e.g., Klatskin tumor at the hilum), malignant stricture.
- Benign: Primary Sclerosing Cholangitis (PSC), post-surgical stricture, Recurrent Pyogenic Cholangitis (RPC) with strictures.
- Extramural (Compression from outside):
- Carcinoma of the head of the pancreas - the classic cause of painless progressive obstructive jaundice.
- Lymphadenopathy at the porta hepatis (e.g., from metastases).
- Mirizzi syndrome: A gallstone impacted in the cystic duct compresses the CHD/CBD.
Lecture Slide Emphasis
- Causes of jaundice: Medical cause vs Surgical cause (stone, tumour, benign stricture) [2].
- Pathology causing malignant biliary obstruction: Carcinoma of duodenum, Periampullary carcinoma, Carcinoma of pancreas, Lymphoma, Carcinoma of gallbladder, Cholangiocarcinoma at hilum (Klatskin tumor), HCC [3].
Beyond the pathophysiological triad, jaundice can be classified in other useful ways:
- Conjugated vs. Unconjugated: Based on lab findings (the "Direct vs. Indirect" split).
- Medical vs. Surgical: A traditional surgical perspective.
- Medical Jaundice: Pre-hepatic and hepatic causes. Management is primarily medical.
- Surgical Jaundice: Almost synonymous with obstructive/cholestatic jaundice, where the problem is mechanical and often requires endoscopic, radiological, or surgical intervention to relieve the blockage.
- Benign vs. Malignant Obstruction: A critical distinction in clinical practice.
Clinical Features: Symptoms and Signs
Connect every symptom and sign back to the underlying pathophysiology. This is what examiners love.
- Yellow Discoloration (Icterus):
- Pathophysiology: Deposition of bilirubin in tissues. Sclera first (due to high elastin affinity), then skin.
- Dark Urine (Bilirubinuria or "Tea-colored"):
- Pathophysiology: Exclusive to conjugated hyperbilirubinemia. Water-soluble conjugated bilirubin is filtered by the kidneys and colors the urine. This is a key differentiator between pre-hepatic/hepatic vs. obstructive causes.
- Pale, Clay-Colored Acholic Stools:
- Pathophysiology: Occurs in complete biliary obstruction. No bilirubin reaches the intestine → no formation of stercobilin (the brown pigment). Stools become pale, greasy (steatorrhea), and foul-smelling.
- Pruritus (Itching):
- Pathophysiology: Primarily associated with cholestasis (intra- or extra-hepatic). Bile salts, which are normally excreted in bile, accumulate in the skin and act as irritants. It is often generalized and worse at night. A hallmark of conditions like Primary Biliary Cholangitis (PBC).
- Abdominal Pain:
- Biliary Colic: Sudden, severe, constant RUQ/epigastric pain, often radiating to the back or right scapula. Caused by a gallstone transiently impacting in the cystic duct or CBD.
- Constant Dull Pain: Suggestive of malignant obstruction (e.g., pancreatic cancer) or chronic inflammation.
- Why pain? Distention of the biliary tree or gallbladder, inflammation of the capsule (liver or pancreas), or direct tumor invasion of nerves.
- Fever & Rigors (Chills):
- Pathophysiology: Indicates infection in the biliary tree, i.e., acute cholangitis. Biliary obstruction + bacterial overgrowth leads to systemic infection. Classic in choledocholithiasis and acute cholangitis.
- Constitutional Symptoms (Weight Loss, Anorexia, Fatigue):
- Pathophysiology: Common in malignancy (e.g., pancreatic cancer, cholangiocarcinoma) or advanced chronic liver disease. Weight loss can also be from malabsorption due to steatorrhea.
- Bleeding Tendency (Easy Bruising, Epistaxis):
- Pathophysiology: The liver synthesizes clotting factors (II, VII, IX, X). In liver failure or prolonged obstructive jaundice, synthesis is impaired. Also, obstructive jaundice causes malabsorption of fat-soluble vitamin K, which is a cofactor for the synthesis of these factors.
- Scleral Icterus: The most sensitive and earliest sign.
- Skin Examination:
- Jaundice: Best seen in natural light. Check the palate.
- Excoriations: Scratch marks from pruritus.
- Spider Angiomas, Palmar Erythema, Dupuytren's Contracture: Signs of chronic liver disease.
- Abdominal Examination:
- Hepatomegaly: May be smooth and tender (e.g., congestion, hepatitis) or hard/nodular (e.g., cirrhosis, metastases).
- Splenomegaly: Suggests portal hypertension (cirrhosis) or hemolysis.
- Ascites: Shifting dullness. Suggests portal hypertension (e.g., cirrhosis) or peritoneal metastases.
- Courvoisier's Sign: A palpable, non-tender gallbladder in the presence of jaundice suggests malignant obstruction of the CBD (e.g., pancreatic head cancer) rather than gallstones. Why? A gallbladder chronically inflamed from stones is fibrotic and cannot dilate. A malignancy causes an acute obstruction, distending a previously healthy, compliant gallbladder.
- Exception: "Double impaction" - a stone in both the cystic duct (causing gallbladder mucocele/hydrops) and the CBD (causing jaundice).
- Epigastric/RUQ Mass: Could be a distended gallbladder (Courvoisier's), a pancreatic mass, enlarged liver, or lymph nodes [4][5].
- Stigmata of Chronic Liver Disease: As above, plus gynecomastia, testicular atrophy, caput medusae, fetor hepaticus.
- Altered Mental Status: In severe cases, can indicate hepatic encephalopathy (from liver failure) or sepsis (from severe cholangitis - part of Reynolds' pentad).
Classic Triads
- Charcot's Triad (Acute Cholangitis): Fever + RUQ pain + Jaundice.
- Reynolds' Pentad (Severe Cholangitis): Charcot's triad + Hypotension/shock + Altered mental status.
- Courvoisier's Law: "In painless jaundice, a palpable gallbladder is unlikely to be due to gallstones."
[1] Senior notes: felixlai.md (Liver cirrhosis) [2] Lecture slides: WCS 056 - Painless jaundice and epigastric mass - by Prof R Poon.ppt (1).pdf (p22) [3] Lecture slides: WCS 056 - Painless jaundice and epigastric mass - by Prof R Poon.ppt (1).pdf (p23) [4] Lecture slides: WCS 056 - Painless jaundice and epigastric mass - by Prof R Poon.ppt (1).pdf (p32) [5] Lecture slides: WCS 056 - Painless jaundice and epigastric mass - by Prof R Poon.ppt (1).pdf (p33)
Active Recall - Jaundice Fundamentals
Differential Diagnosis of Jaundice
The differential diagnosis of jaundice is vast, but a systematic approach based on the pathophysiological triad (pre-hepatic, hepatic, post-hepatic) is key. The clinical presentation (painful vs. painless, acute vs. chronic, presence of fever) and simple lab/imaging findings can quickly narrow the list.
The initial, most critical step is to determine if the jaundice is conjugated or unconjugated. This splits the differential in two. Remember: conjugated bilirubin is water-soluble and appears in the urine (bilirubinuria), while unconjugated bilirubin is not.
Here is a visual algorithm to guide your clinical reasoning:
Pathophysiology: Overproduction of bilirubin overwhelms a normal liver's conjugation capacity.
- Hemolytic Anemias: Increased RBC breakdown.
- Intrinsic RBC defects: Hereditary spherocytosis, G6PD deficiency (common in Southern Chinese), sickle cell disease.
- Extrinsic causes: Autoimmune hemolytic anemia, malaria, mechanical heart valves, microangiopathic hemolytic anemia (e.g., DIC).
- Why jaundice? The liver's UGT enzyme system is saturated. Bilirubin is primarily unconjugated, so urine is NOT dark (no bilirubinuria), but urine urobilinogen is high.
- Ineffective Erythropoiesis: Premature destruction of RBC precursors in bone marrow (e.g., megaloblastic anemias from B12/folate deficiency, thalassemia).
- Large Hematoma/Bruise Resorption: Breakdown of extravasated blood releases heme.
- Gilbert's Syndrome: The most common inherited cause. Mild, chronic unconjugated hyperbilirubinemia due to reduced UGT1A1 activity (to ~30% of normal). It's benign, often triggered by fasting, illness, or stress.
Pathophysiology: Hepatocyte dysfunction impairs uptake, conjugation, AND excretion. Lab shows a mixed pattern (both conjugated and unconjugated bilirubin elevated, with conjugated often >50%), markedly elevated transaminases (AST/ALT), and variable elevation in ALP.
- Viral Hepatitis: Hepatitis A, B, C, D, E. Chronic Hepatitis B is a leading cause of cirrhosis and HCC in Hong Kong [1].
- Alcoholic Liver Disease: Spectrum from fatty liver → alcoholic hepatitis → cirrhosis. AST:ALT ratio often >2:1.
- Non-Alcoholic Fatty Liver Disease (NAFLD)/NASH: Now a leading cause of chronic liver disease worldwide, associated with metabolic syndrome.
- Drug-Induced Liver Injury (DILI): A huge list. Can be hepatocellular (e.g., paracetamol overdose, statins), cholestatic (e.g., amoxicillin-clavulanate), or mixed.
- Autoimmune Hepatitis: More common in young to middle-aged women, with positive autoantibodies (ANA, ASMA, anti-LKM1).
- Cirrhosis (any cause): End-stage liver disease. In HK, HBV is the most common cause [1]. Jaundice indicates decompensation.
- Genetic/Metabolic Disorders:
- Wilson's Disease: Copper accumulation. Look for Kayser-Fleischer rings, neurological symptoms, Coombs-negative hemolytic anemia.
- Hemochromatosis: Iron overload. Look for bronze skin diabetes, cardiomyopathy, arthropathy.
- Ischemic Hepatitis ("Shock Liver"): From profound hypotension or heart failure. AST/ALT can rise to the thousands.
Pathophysiology: Mechanical blockage of bile flow. Lab shows a cholestatic pattern: conjugated hyperbilirubinemia, disproportionately high ALP and GGT relative to AST/ALT. The key investigation is an abdominal ultrasound to check for biliary dilation.
It is critical to classify obstructive causes by their anatomic relation to the bile duct wall and by level of obstruction, as this guides management [6][7].
- Intraluminal (Inside the duct):
- Choledocholithiasis (CBD Stone): Most common cause of painful obstructive jaundice. Stone migrates from gallbladder, causing intermittent obstruction, pain (biliary colic), and risk of acute cholangitis (fever, pain, jaundice - Charcot's triad).
- Recurrent Pyogenic Cholangitis (RPC - 'Hong Kong Disease'): Characterized by intrahepatic pigment stone formation, strictures, and recurrent bacterial infections. A key cause of obstructive jaundice in Southeast Asia [8].
- Parasitic infestation (e.g., Clonorchis sinensis from raw fish, Ascaris lumbricoides).
- Mural (Abnormality of the duct wall itself):
- Cholangiocarcinoma: Malignancy of the bile ducts. Perihilar (Klatskin tumor) is the most common type. Why painless? It's a slow-growing, infiltrative tumor that doesn't cause acute distention.
- Primary Sclerosing Cholangitis (PSC): Idiopathic inflammation and fibrosis causing multifocal strictures of intra- and extra-hepatic ducts. Strongly associated with Ulcerative Colitis. Presents with pruritus, jaundice, and episodes of cholangitis [9].
- Malignant Stricture (e.g., from metastatic lymph nodes).
- Benign Stricture (e.g., post-surgical, post-traumatic, chronic pancreatitis).
- Extramural (Compression from outside the duct):
- Carcinoma of the Head of the Pancreas: The classic cause of painless, progressive obstructive jaundice in the elderly. The tumor compresses the intrapancreatic portion of the CBD. Courvoisier's sign (palpable gallbladder) is a classic finding [10].
- Periampullary Carcinoma: Tumors arising from the ampulla of Vater, duodenal mucosa, or distal CBD. Can also cause painless jaundice.
- Lymphadenopathy at the porta hepatis (from metastases, lymphoma, TB).
- Mirizzi Syndrome: Impacted stone in the cystic duct or Hartmann's pouch causes extrinsic inflammation and compression of the common hepatic duct, leading to jaundice and cholangitis. It is an exception to Courvoisier's law (can cause jaundice with a palpable gallbladder due to associated acute cholecystitis/mucocele) [11].
- Pancreatic Pseudocyst / Chronic Pancreatitis causing fibrosis and compression.
Key Clinical Pearls
- Painless Progressive Jaundice + Palpable Gallbladder (Courvoisier's Sign) = Malignant Obstruction (e.g., Pancreatic Cancer) until proven otherwise.
- Painful Jaundice + Fever (Charcot's Triad) = Acute Cholangitis, most commonly from choledocholithiasis.
- Painless Jaundice + History of IBD (Ulcerative Colitis) = Think of PSC.
- Pediatric Jaundice: Must differentiate physiological from pathological. Causes include biliary atresia, neonatal hepatitis, metabolic disorders, and hemolytic disease of the newborn.
- Post-operative Jaundice: Consider: 1) Pre-hepatic (hemolysis from transfusion), 2) Hepatic (drugs like anesthetic agents, sepsis, hypotension-induced ischemia), 3) Post-hepatic (iatrogenic bile duct injury) [12].
- Hepatocellular Carcinoma (HCC): Can present with jaundice via several mechanisms: 1) Decompensation of underlying cirrhosis, 2) Mass effect compressing central bile ducts, 3) Tumor invasion into bile ducts (icteric-type HCC), 4) Hemobilia (bleeding into biliary tree) [13].
- Differentiating Stone vs. Tumor: Crucial in clinical exams.
| Feature | Stone (Choledocholithiasis) | Tumor (e.g., Pancreatic CA) |
|---|---|---|
| Pain | Painful (biliary colic) as stone passes | Painless (until advanced) |
| Jaundice | Intermittent (stone may pass) | Progressive and unremitting |
| Fever/Cholangitis | Common (bacterial overgrowth behind obstruction) | Less common until late-stage stent blockage |
| Onset | Acute | Insidious |
| Gallbladder | Usually not palpable (fibrotic from chronic cholecystitis) | May be palpable (Courvoisier's sign) if distal CBD obstruction |
| Constitutional Sx | Less prominent unless septic | Prominent (weight loss, anorexia) |
High Yield Summary — Differential Diagnosis of Jaundice
- Causes of jaundice: Medical cause vs Surgical cause (stone, tumour, benign stricture) [14].
- Pathology producing jaundice and epigastric mass: Hepatomegaly secondary to biliary obstruction, Hepatomegaly due to metastases or HCC, Lymph node metastases to the coeliac axis or porta hepatis, Carcinoma of stomach with metastatic lymph node in the porta hepatis, Distended stomach due to duodenal obstruction by tumor which obstruct the bile duct as well [15].
- Physical Examination findings in malignant obstruction: Jaundice, Stigmata of chronic liver disease, Pruritus, Courvoisier’s law, Troisier’s sign (Virchow’s node), Hepatomegaly, Sister Joseph nodule, Ascites [16].
References
[1] Senior notes: felixlai.md (Liver cirrhosis) [6] Senior notes: felixlai.md (Causes according to level of obstruction) [7] Senior notes: maxim.md (Differential diagnosis of obstructive jaundice) [8] Senior notes: felixlai.md (Recurrent pyogenic cholangitis) [9] Senior notes: felixlai.md (Primary sclerosing cholangitis) [10] Senior notes: felixlai.md (Courvoisier's law) [11] Senior notes: felixlai.md (Mirizzi syndrome) [12] Senior notes: maxim.md (DDx of post-operative jaundice) [13] Senior notes: felixlai.md (Hepatocellular carcinoma) [14] Lecture slides: WCS 056 - Painless jaundice and epigastric mass - by Prof R Poon.ppt (1).pdf (p22) [15] Lecture slides: WCS 056 - Painless jaundice and epigastric mass - by Prof R Poon.ppt (1).pdf (p32) [16] Lecture slides: Malignant biliary obstruction.pdf (p6)
Active Recall - Differential Diagnosis of Jaundice
Diagnostic Criteria, Algorithm, and Investigations for Jaundice
The diagnostic approach to jaundice is a classic example of clinical reasoning: start with non-invasive, cheap, and informative tests to categorize the problem, then proceed to more targeted investigations.
Before ordering tests, the history and exam provide critical clues that direct the entire workup.
- History: Focus on the onset (acute vs. chronic), associated symptoms (pain, fever, pruritus, weight loss), stool and urine color, drug history, alcohol use, travel, and personal/family history of liver or hematological disease. The key is to differentiate medical (pre-hepatic/hepatic) from surgical (obstructive) causes [17].
- Physical Examination:
- Jaundice, Stigmata of chronic liver disease, Pruritus, Courvoisier’s law, Troisier’s sign (Virchow’s node), Hepatomegaly, Sister Joseph nodule, Ascites [18].
- Courvoisier's Law is a cornerstone: a palpable, non-tender gallbladder in a jaundiced patient suggests malignant obstruction (e.g., pancreatic head cancer) rather than gallstones. Why? Chronic gallstone inflammation causes a fibrotic, non-distensible gallbladder. Acute malignant obstruction distends a previously normal gallbladder [10][19].
- Look for signs of chronic liver disease (spider nevi, palmar erythema, ascites) and clues to malignancy (cachexia, Virchow's node).
The following algorithm synthesizes a logical, stepwise approach to diagnosing jaundice, integrating history, lab findings, and imaging.
Investigation Modalities: Key Findings and Interpretation
- Complete Blood Count (CBC):
- Leukocytosis: Suggests infection (e.g., acute cholangitis).
- Anemia: May be due to chronic disease, hemolysis, or bleeding from esophageal varices.
- Thrombocytopenia: Could indicate hypersplenism from portal hypertension (cirrhosis) or consumptive coagulopathy.
- Liver Function Tests (LFTs): The pattern is everything.
- Bilirubin Fractionation: Direct (conjugated) vs. Indirect (unconjugated). Conjugated hyperbilirubinemia implies a hepatic or post-hepatic problem.
- Transaminases (AST, ALT): Markers of hepatocellular injury. Very high levels (>1000 U/L) suggest acute viral hepatitis, ischemic hepatitis, or toxin-induced injury. An AST:ALT ratio >2:1 is suggestive of alcoholic liver disease.
- Alkaline Phosphatase (ALP) & Gamma-Glutamyl Transferase (GGT): Markers of cholestasis (impaired bile flow). A disproportionate elevation of ALP and GGT relative to AST/ALT points to an obstructive or infiltrative process. GGT confirms the hepatic origin of an elevated ALP.
- Albumin & Prothrombin Time (PT/INR): Markers of hepatic synthetic function. Low albumin (long half-life) suggests chronic liver disease. Prolonged PT that corrects with Vitamin K points to malabsorption due to obstructive jaundice; if it doesn't correct, it indicates significant hepatocellular failure.
- Viral Serology: HBsAg, Anti-HCV, etc. Essential in Hong Kong given HBV endemicity [1].
- Inflammatory Markers (CRP, ESR): Elevated in infective/inflammatory conditions (cholangitis, autoimmune hepatitis).
- Tumor Markers: Never diagnostic on their own, used in conjunction with imaging.
- CA 19-9: Associated with pancreatic, biliary, and gastric cancers. Also elevated in benign biliary obstruction (e.g., cholangitis, stones) and cholestasis, limiting its specificity [20][21].
- AFP (Alpha-fetoprotein): Marker for Hepatocellular Carcinoma (HCC). Levels >400 ng/mL are highly suggestive in the right clinical context. Also elevated in germ cell tumors and active liver regeneration (e.g., hepatitis).
- CEA (Carcinoembryonic Antigen): Raised in colorectal, gastric, pancreatic, and lung cancers. Non-specific.
- Autoantibodies:
- Anti-Mitochondrial Antibody (AMA): >95% specific for Primary Biliary Cholangitis (PBC).
- Anti-Nuclear Antibody (ANA), Anti-Smooth Muscle Antibody (ASMA): Seen in Autoimmune Hepatitis.
- p-ANCA: Can be positive in Primary Sclerosing Cholangitis (PSC).
Lecture Slide Emphasis
Case Example LFTs: Serum bilirubin 240 µmol/L, ALP 580 u/L, ALT 60 u/L, AST 55 u/L. This is a classic cholestatic pattern (high bilirubin and ALP with relatively normal transaminases), pointing to an obstructive or intrahepatic cholestatic cause [22].
- Ultrasonography (USG) Abdomen: The First and Most Important Imaging Test.
- Why first? It's non-invasive, cheap, has no radiation, and answers the critical question: Are the bile ducts dilated?
- Key Findings:
- Dilated Intrahepatic and/or Extrahepatic Bile Ducts: Confirms obstructive (post-hepatic) jaundice. The level of dilation (intrahepatic only vs. both) helps localize the obstruction.
- CBD Diameter: >8mm is generally considered dilated (allow 1mm per decade after age 50). A normal CBD on USG does not completely rule out obstruction (especially distal CBD stones hidden by bowel gas).
- Cause: May visualize gallstones (in gallbladder or CBD), a mass in the pancreas or liver, or lymphadenopathy.
- Liver Parenchyma: Can show signs of cirrhosis, fatty liver, or mass lesions.
- Computed Tomography (CT) Abdomen with Contrast:
- Role: Excellent for staging malignancies (pancreatic cancer, cholangiocarcinoma) and assessing vascular involvement. Better than USG for visualizing the pancreas and retroperitoneum.
- Key Findings for Pancreatic Cancer: Hypoattenuating pancreatic mass, double-duct sign (dilated CBD and pancreatic duct), and assessment of resectability (encasement of SMA, SMV, etc.) [23].
- Magnetic Resonance Cholangiopancreatography (MRCP):
- Role: The best non-invasive test to visualize the biliary and pancreatic ductal anatomy. It has largely replaced diagnostic ERCP. It can show stones, strictures, and masses without the risk of pancreatitis.
- Key Findings: Filling defects (stones), focal strictures with proximal dilation (tumor, PSC), and the "beaded" appearance of PSC.
- Endoscopic Ultrasound (EUS):
- Role: Combines endoscopy and ultrasound. Excellent for tissue acquisition (fine-needle aspiration/FNA) of pancreatic or periampullary masses and for detecting small CBD stones missed by USG.
- Endoscopic Retrograde Cholangiopancreatography (ERCP):
- Role: Primarily therapeutic, not diagnostic. It is an invasive procedure with risks (pancreatitis, bleeding, perforation). Used when intervention is anticipated.
- Indications: 1) To relieve obstruction (stone extraction, stent placement), 2) To obtain brushings/biopsy from a stricture, 3) When MRCP is equivocal and clinical suspicion for obstruction is high.
- Percutaneous Transhepatic Cholangiography (PTC) & Drainage (PTBD):
- Role: Used when ERCP fails or is not possible (e.g., altered anatomy, previous gastric surgery) or for proximal/hilar obstructions (e.g., Klatskin tumor). A needle is passed through the skin into a dilated intrahepatic duct, contrast is injected (PTC), and a drain can be placed (PTBD) to decompress the system.
Imaging Modalities Summary
- Imaging modalities for obstructive jaundice: Ultrasonography, Endoscopic ultrasonography, Endoscopic retrograde cholangiopancreatography (ERCP), Percutaneous transhepatic cholangiography (PTC) and drainage (PTBD), Computed tomography (CT), Magnetic resonance imaging (MRI) and cholangiopancreatography (MRCP), Positron emission tomography (PET) [24].
- Ultrasound/CT: Size of bile duct, Level of obstruction, Cause of obstruction, Other associated features. Malignant disease: staging. Benign disease: gallstones > cx [25].
- Role: Not routine. Used when the cause of hepatocellular or intrahepatic cholestatic jaundice remains unclear after exhaustive non-invasive testing (e.g., diagnosing autoimmune hepatitis, grading/staging NASH, confirming PBC or PSC when serology/MRCP is ambiguous).
- Acute Cholangitis (Tokyo Guidelines):
- Suspected Diagnosis: A. Systemic Inflammation (Fever/Shivers OR lab evidence: ↑WBC, ↑CRP) AND B. Cholestasis (Jaundice OR abnormal LFTs: ↑ALP, GGT, AST, ALT).
- Definite Diagnosis: Suspected diagnosis AND C. Imaging evidence of biliary dilation or an etiology (stone, stricture, stent) [26].
- Primary Biliary Cholangitis (PBC): Diagnosis requires 2 of 3: 1) ALP ≥ 1.5x ULN, 2) Positive AMA (≥1:40), 3) Liver biopsy showing non-suppurative destructive cholangitis [27].
- Primary Sclerosing Cholangitis (PSC): Diagnosis is based on cholangiographic findings (MRCP or ERCP) showing multifocal strictures and segmental dilatations of the intra- and/or extra-hepatic bile ducts, after excluding secondary causes (e.g., stones, surgery) [9].
- Hepatocellular Carcinoma (HCC): In patients with cirrhosis, a focal liver lesion >1 cm with typical imaging characteristics (arterial phase hyperenhancement and venous/delayed phase "washout" on multiphase CT or MRI) is diagnostic without the need for biopsy.
References
[1] Senior notes: felixlai.md (Liver cirrhosis) [10] Senior notes: felixlai.md (Courvoisier's law) [17] Senior notes: maxim.md (Important questions in history taking) [18] Lecture slides: Malignant biliary obstruction.pdf (p6) [19] Senior notes: felixlai.md (Diagnosis - Courvoisier's law) [20] Senior notes: felixlai.md (CA 19-9) [21] Senior notes: maxim.md (Tumor markers) [22] Lecture slides: WCS 056 - Painless jaundice and epigastric mass - by Prof R Poon.ppt (1).pdf (p4) [23] Senior notes: felixlai.md (CT findings in pancreatic cancer) [24] Lecture slides: WCS 056 - Painless jaundice and epigastric mass - by Prof R Poon.ppt (1).pdf (p34) [25] Lecture slides: Malignant biliary obstruction.pdf (p10) [26] Senior notes: felixlai.md (Diagnostic criteria for acute cholangitis) [27] Senior notes: felixlai.md (Diagnostic criteria for PBC)
Active Recall - Diagnosis of Jaundice
Management Algorithm and Treatment Modalities for Jaundice
The management of jaundice is entirely directed at treating its underlying cause. However, the approach to obstructive (surgical) jaundice involves specific, often urgent, interventions to relieve the blockage and treat complications like infection. The management of hepatic (medical) jaundice is primarily supportive and disease-specific.
The cornerstone of managing obstructive jaundice is biliary decompression – relieving the blockage to allow bile to flow. The method depends on the cause, level of obstruction, patient fitness, and whether the goal is curative or palliative.
Before specific treatment, address the systemic effects of jaundice and cholestasis:
- Correct Coagulopathy: Administer parenteral Vitamin K (e.g., 10 mg IV/IM) to correct PT/INR prolonged due to malabsorption. Fresh Frozen Plasma (FFP) may be needed for urgent procedures.
- Manage Pruritus: Cholestyramine (bile acid sequestrant), antihistamines, or rifampicin.
- Nutritional Support: Fat-soluble vitamin (A, D, E, K) supplementation. Consider medium-chain triglycerides (MCTs) for steatorrhea as they are absorbed without bile salts.
- Renal Protection: Maintain hydration; obstructive jaundice predisposes to hepatorenal syndrome.
The following algorithm outlines the decision-making pathway, from initial stabilization to definitive therapy.
Treatment Modalities for Specific Conditions
A life-threatening infection requiring urgent intervention. Remember the mnemonic RAD: Resuscitation, Antibiotics, Drainage [28].
- Resuscitation: IV fluids, monitor vitals, correct electrolytes.
- Antibiotics: IV broad-spectrum antibiotics covering enteric Gram-negatives and anaerobes (e.g., piperacillin-tazobactam or cefuroxime + metronidazole) [29].
- Biliary Drainage (Decompression): Required urgently if no response to antibiotics within 12-24 hours or immediately if Reynold's pentad (shock, altered mentation) is present.
- First line: ERCP with biliary stenting (and/or sphincterotomy/stone extraction if feasible). This relieves pressure, drains infected bile, and allows antibiotics to penetrate [30].
- Alternatives: PTBD (if ERCP fails, contraindicated, or for proximal obstructions) or, rarely, surgical common bile duct exploration (ECBD).
- Definitive Treatment: Once sepsis is controlled, treat the underlying cause (e.g., cholecystectomy for gallstones).
- Symptomatic or Complicated Stones (causing jaundice, cholangitis, pancreatitis):
- ERCP with Sphincterotomy and Stone Extraction is the standard first-line therapy [31]. Techniques include balloon trawl, basket extraction, or mechanical lithotripsy for large stones.
- Timing: For concomitant acute biliary pancreatitis, ERCP is indicated within 24-72 hours if there is persistent biliary obstruction or cholangitis.
- Subsequent Cholecystectomy: Laparoscopic cholecystectomy should be performed during the same admission or within 2-4 weeks after ERCP to prevent recurrent biliary events.
- Asymptomatic CBD Stones: Management is debated; ERCP may be considered if stones are large (>1cm) or if the patient is undergoing cholecystectomy.
Management hinges on resectability (curative intent) vs. unresectability (palliative intent) [32].
A. Curative-Intent Treatment (Resectable Disease)
- Pre-operative Preparation:
- Pre-operative Biliary Drainage is controversial. Traditionally used to lower bilirubin (< 50 µmol/L) to reduce surgical risks (coagulopathy, renal impairment, infection). However, it can increase complications (stent occlusion, cholangitis). Current guidelines suggest avoiding routine drainage if surgery can be performed within 1-2 weeks. In practice (e.g., QMH), drainage is often done due to surgical waiting times [33].
- Nutritional support and correction of coagulopathy.
- Surgical Resection:
- Carcinoma of Head of Pancreas/Periampullary: Pancreaticoduodenectomy (Whipple procedure). Pylorus-preserving (PPPD) is often preferred.
- Cholangiocarcinoma:
- Perihilar (Klatskin): Major hepatectomy (often extended hepatectomy) + bile duct resection + caudate lobectomy + Roux-en-Y Hepaticojejunostomy.
- Distal CBD: Pancreaticoduodenectomy (similar to pancreatic head cancer).
- Intrahepatic: Partial hepatectomy.
- Gallbladder Carcinoma: Radical cholecystectomy (cholecystectomy + wedge resection of liver segments IVb/V + portal lymphadenectomy).
- Adjuvant Therapy: Chemotherapy (e.g., Gemcitabine + Capecitabine for pancreas; Capecitabine for biliary) is standard post-resection to improve survival.
B. Palliative-Intent Treatment (Unresectable Disease) Goals: Relieve obstruction, treat sepsis, control pain [34].
- Biliary Decompression:
- Endoscopic Stenting (ERCP): First-line for distal CBD obstructions. Self-expandable metallic stents (SEMS) are preferred over plastic for longer patency if life expectancy >3-4 months.
- Percutaneous Transhepatic Biliary Drainage (PTBD): Indicated for proximal/hilar obstructions, or when ERCP fails or is contraindicated (e.g., altered anatomy like Roux-en-Y, gastric outlet obstruction) [35].
- Duodenal Stenting or Gastrojejunostomy: For malignant gastric outlet obstruction.
- Pain Control: Opioids, celiac plexus neurolysis (EUS or CT-guided).
- Systemic Therapy: Chemotherapy (e.g., FOLFIRINOX, Gemcitabine-based regimens) for pancreatic/biliary cancers.
Procedure Specifics
ERCP Contraindications [36]:
- Unstable cardiopulmonary status
- Suspected bowel perforation
- Altered upper GI anatomy (e.g., Billroth II gastrectomy, Roux-en-Y reconstruction — makes access technically difficult)
- Gastric outlet obstruction
Management is challenging due to intrahepatic stones and strictures.
- Acute Episode: Managed as acute cholangitis (RAD). PTBD is often more effective than ERCP for draining the frequently affected intrahepatic ducts.
- Definitive/Preventive Therapy: Aims to break the cycle of stasis-infection-stone formation.
- Endoscopic/Interventional: Repeated ERCP sessions for stone clearance and stricture dilation.
- Surgical: Hepatectomy of the atrophic, stone-laden liver segment (often left lateral section) + Roux-en-Y Hepaticojejunostomy to provide free biliary drainage. This is indicated for localized disease, failed non-operative management, or suspicion of cholangiocarcinoma [37].
Complete surgical excision is mandatory due to high risk of cholangiocarcinoma.
- Procedure: Complete cyst excision + Roux-en-Y Hepaticojejunostomy.
- Why excision? Removes the premalignant epithelium. Internal drainage procedures alone (e.g., cyst-enterostomy) are contraindicated as they leave the cancer risk.
- Type V (Caroli's Disease): If unilateral, hemihepatectomy. If diffuse, may require liver transplantation.
- PSC: No cure except liver transplantation for end-stage disease. Dominant strictures causing obstruction/cholangitis may be treated with endoscopic balloon dilation ± stenting. Ursodeoxycholic acid (UDCA) is used but of limited proven benefit.
- PBC: First-line treatment is UDCA 13-15 mg/kg/day, which slows disease progression. Obeticholic acid is second-line. Liver transplantation for end-stage disease.
High Yield Summary — Management of Jaundice
- Management is cause-directed: first determine whether jaundice is pre-hepatic, hepatic, or post-hepatic, then treat the underlying pathology.
- Obstructive jaundice with cholangitis is an emergency: Resuscitation + IV antibiotics + urgent biliary decompression.
- ERCP is first-line for distal obstructive jaundice and choledocholithiasis; PTBD is preferred when ERCP fails, is contraindicated, or the obstruction is proximal/hilar.
- CBD stones: ERCP with sphincterotomy and stone extraction, followed by laparoscopic cholecystectomy.
- Malignant biliary obstruction: resectable disease proceeds to staging and surgery; unresectable disease is managed palliatively with stenting/PTBD, symptom control, and systemic therapy.
- Choledochal cysts require complete excision + Roux-en-Y hepaticojejunostomy because of malignant potential.
- PSC/PBC are primarily medical diseases; liver transplantation is the definitive treatment for end-stage disease.
References
[28] Senior notes: maxim.md (Acute management of cholangitis - RAD) [29] Lecture slides: GC 200. RUQ pain, jaundice and fever Cholecytitis and cholangitis Imaging of GI system.pdf (p13) [30] Lecture slides: GC 200. RUQ pain, jaundice and fever Cholecytitis and cholangitis Imaging of GI system.pdf (p14) [31] Senior notes: maxim.md (Choledocholithiasis management) [32] Lecture slides: Malignant biliary obstruction.pdf (p18) [33] Lecture slides: WCS 056 - Painless jaundice and epigastric mass - by Prof R Poon.ppt (1).pdf (p67) [34] Lecture slides: Malignant biliary obstruction.pdf (p30) [35] Senior notes: felixlai.md (PTBD indications) [36] Senior notes: felixlai.md (ERCP contraindications) [37] Senior notes: felixlai.md (RPC surgical treatment)
Active Recall - Management of Jaundice
Complications of Jaundice
Jaundice itself is a sign, not a disease, so its "complications" are really the consequences of the underlying disorder and the physiological disturbances caused by the accumulation of bilirubin and, in the case of cholestasis, retained bile constituents. Understanding these complications is crucial because they often dictate the urgency and goals of management.
This is a critical area in pediatrics. Unconjugated bilirubin (UCB) is lipid-soluble and can cross the blood-brain barrier, especially when it is unbound to albumin (free bilirubin).
- Acute Bilirubin Encephalopathy (ABE): The acute, potentially reversible neurotoxic effects of high UCB.
- Pathophysiology: Free UCB enters neurons, disrupts mitochondrial function, and induces apoptosis and necrosis. Risk is highest in neonates with immature blood-brain barriers, hemolysis, acidosis, or sepsis.
- Clinical Phases:
- Early (1-2 days): Lethargy, hypotonia, poor suck.
- Intermediate (mid-first week): Hypertonia (especially of extensor muscles), fever, retrocollis/opisthotonos (backward arching).
- Advanced (after first week): Pronounced hypertonia, high-pitched cry, seizures, coma.
- Kernicterus: The chronic, permanent neurological sequelae of severe, untreated ABE.
- Pathophysiology: Permanent neuronal injury and bilirubin staining of the basal ganglia, hippocampus, and brainstem nuclei.
- Clinical Features: Choreoathetoid cerebral palsy, sensorineural hearing loss, upward gaze palsy, dental enamel dysplasia, and intellectual deficits.
Key Concept
Kernicterus is a preventable tragedy. Vigilant monitoring of neonatal jaundice and prompt treatment (phototherapy, exchange transfusion) when levels approach the neurotoxic threshold are essential.
When bile flow is impaired, substances normally excreted in bile accumulate systemically, causing a cascade of problems.
- Pruritus (Itching): One of the most debilitating symptoms.
- Pathophysiology: Not fully understood, but likely mediated by bile salts accumulating in the skin and activating itch receptors (e.g., TGR5, MRGPRX4). Other theories involve endogenous opioids and lysophosphatidic acid.
- Malabsorption and Fat-Soluble Vitamin (A, D, E, K) Deficiency:
- Pathophysiology: Bile acids are essential for emulsifying dietary fats. Their absence leads to steatorrhea (fatty, foul-smelling, pale stools). The fat-soluble vitamins (A, D, E, K) are absorbed with fats, so their absorption is also impaired.
- Specific Deficiencies:
- Vitamin K: Leads to a coagulopathy, prolonging PT/INR. This is a classic finding in obstructive jaundice and can be corrected with parenteral Vitamin K.
- Vitamin D & Calcium: Contribute to hepatic osteodystrophy (osteopenia, osteoporosis, osteomalacia). The mechanism is multifactorial: malabsorption, direct toxic effects of retained substances on osteoblasts, and metabolic disturbances.
- Vitamin A: Can cause night blindness and dry eyes (xerophthalmia).
- Hyperlipidemia and Xanthomas:
- Pathophysiology: Impaired excretion of cholesterol in bile leads to elevated serum cholesterol. Lipoprotein-X, an abnormal lipoprotein, also accumulates. This can lead to cholesterol deposition in skin (xanthelasma, tuberous xanthomas) and tendons.
- Coagulopathy: As mentioned, from Vitamin K deficiency. In advanced liver disease, there is also impaired hepatic synthesis of clotting factors (II, VII, IX, X), which is not corrected by Vitamin K.
- Endotoxemia and Immune Dysfunction:
- Pathophysiology: The liver's Kupffer cells (resident macrophages) normally clear gut-derived endotoxins (bacterial lipopolysaccharides). In obstructive jaundice and liver failure, this function is impaired, leading to systemic endotoxemia. This, combined with impaired cell-mediated immunity and reticuloendothelial function, predisposes to bacterial infections, sepsis, and poor wound healing [38][39].
- Renal Dysfunction (Hepatorenal Syndrome - HRS):
- Pathophysiology: Advanced liver disease and portal hypertension lead to profound splanchnic vasodilation, reducing effective arterial blood volume. This triggers intense renal vasoconstriction, leading to acute kidney injury (functional, not structural). Obstructive jaundice itself also increases the risk of acute kidney injury.
- Cirrhosis and Portal Hypertension: Chronic cholestasis (e.g., from PBC, PSC, chronic obstruction) leads to progressive hepatic fibrosis, nodular regeneration, and ultimately cirrhosis. This brings its own set of life-threatening complications:
- Variceal Hemorrhage: From portal hypertensive gastropathy and esophageal/gastric varices.
- Ascites and Spontaneous Bacterial Peritonitis (SBP).
- Hepatic Encephalopathy.
Lecture Slide Emphasis
- Pathophysiological effects of malignant biliary obstruction: Impaired protein synthesis, Impaired clotting factor synthesis, Impaired gluconeogenesis, Impaired ketogenesis, Endotoxemia, ↓ reticulo-endothelial function, ↓ cell-mediated immunity [39]. * Jaundice → coagulopathy, malabsorption, malnutrition & immune dysfunction → studies in 80’s: higher anastomotic leak, haemorrhage & renal failure [40]. * Cause of mortality in MBO: Biliary sepsis, Cancer cachexia, Liver failure [41].
- Acute Cholangitis:
- Can rapidly progress from Charcot's triad (fever, pain, jaundice) to Reynolds' pentad (+ shock and altered mental status), indicating severe sepsis or septic shock.
- Liver abscess formation.
- Multi-organ failure (renal, respiratory, circulatory).
- Recurrent Pyogenic Cholangitis (RPC):
- Secondary Biliary Cirrhosis from chronic obstruction and recurrent infection.
- Cholangiocarcinoma – a feared long-term complication due to chronic inflammation and epithelial injury [42].
- Liver abscess, pancreatitis, biliary fistula formation (e.g., to duodenum or abdominal wall).
- Primary Sclerosing Cholangitis (PSC):
- Dominant strictures causing worsening obstruction and cholangitis.
- Very high lifetime risk of Cholangiocarcinoma (up to 10-15%). Screening with MRI/MRCP and CA19-9 is recommended.
- Progression to cirrhosis and liver failure.
- Primary Biliary Cholangitis (PBC):
- Hepatic osteodystrophy is particularly prominent.
- Hyperlipidemia (but interestingly, this does not seem to increase atherosclerotic risk significantly).
- Progression to cirrhosis and increased risk of Hepatocellular Carcinoma (HCC), especially in advanced disease.
- Malignant Biliary Obstruction (e.g., Pancreatic Cancer, Cholangiocarcinoma):
- Cancer cachexia: Severe weight loss and muscle wasting from systemic inflammation and metabolic dysregulation.
- Duodenal/Gastric Outlet Obstruction: From direct tumor invasion.
- Pain: From tumor invasion of the retroperitoneal nerves (e.g., celiac plexus).
- Metastatic disease (liver, peritoneum, lung).
- Hepatocellular Carcinoma (HCC):
- Tumor rupture leading to life-threatening hemoperitoneum.
- Obstructive jaundice from tumor invasion of bile ducts (icteric-type HCC) or compression.
- Paraneoplastic syndromes (e.g., hypercalcemia, polycythemia, hypoglycemia).
- Endoscopic Retrograde Cholangiopancreatography (ERCP):
- Acute Pancreatitis (3-5%): The most common major complication. Why? Trauma to the pancreatic duct orifice or hydrostatic injury from contrast injection.
- Bleeding (1-2%): Post-sphincterotomy.
- Perforation (< 1%): Duodenal or bile duct.
- Cholangitis/Cholecystitis: From incomplete drainage or introducing infection.
- Sedation-related complications (cardiopulmonary).
- Percutaneous Transhepatic Biliary Drainage (PTBD):
- Hemorrhage (5%): Laceration of hepatic artery or portal vein during needle pass. Can be catastrophic.
- Bile Leak and Peritonitis.
- Catheter dislodgement or occlusion.
- Pleural complications (pneumothorax, hemothorax) if a high puncture is made.
- Pre-operative Biliary Drainage (Stenting/PTBD):
- While intended to reduce surgical risk, it can increase overall complication rates due to stent-related issues: cholangitis (26%), blocked stent (15%), pancreatitis (7%) [43].
- Major Hepatobiliary Surgery (e.g., Whipple, Hepatectomy):
- Anastomotic Leak: Pancreaticojejunostomy leak is the most feared and common major complication after Whipple surgery, leading to intra-abdominal abscess, sepsis, and hemorrhage.
- Delayed Gastric Emptying.
- Post-hepatectomy Liver Failure: The "50-50 rule" (Bilirubin >50 µmol/L and INR >1.7 on post-op day 5) predicts high mortality.
- Bile Leak.
- Hemorrhage.
- Infection.
High Yield Summary — Complications of Jaundice
Complications of jaundice span from acute neurological injury in babies to the insidious consequences of chronic liver disease and the high stakes of cancer and its treatments. Your management plan must always anticipate and try to prevent these complications—whether it's giving Vitamin K, draining an infected biliary system urgently, or providing nutritional support before major surgery.
References
[38] Lecture slides: WCS 056 - Painless jaundice and epigastric mass - by Prof R Poon.ppt (1).pdf (p64) [39] Lecture slides: WCS 056 - Painless jaundice and epigastric mass - by Prof R Poon.ppt (1).pdf (p66) [40] Lecture slides: Malignant biliary obstruction.pdf (p24) [41] Lecture slides: Malignant biliary obstruction.pdf (p29) [42] Senior notes: felixlai.md (Complications of RPC) [43] Lecture slides: Malignant biliary obstruction.pdf (p26)
Active Recall - Complications of Jaundice
Classic Triads
- Charcot's Triad (Acute Cholangitis): Fever + RUQ pain + Jaundice.
- Reynolds' Pentad (Severe Cholangitis): Charcot's triad + Hypotension/shock + Altered mental status.
- Courvoisier's Law: "In painless jaundice, a palpable gallbladder is unlikely to be due to gallstones."
High Yield Summary — Differential Diagnosis of Jaundice
- Causes of jaundice: Medical cause vs Surgical cause (stone, tumour, benign stricture) [14].
- Pathology producing jaundice and epigastric mass: Hepatomegaly secondary to biliary obstruction, Hepatomegaly due to metastases or HCC, Lymph node metastases to the coeliac axis or porta hepatis, Carcinoma of stomach with metastatic lymph node in the porta hepatis, Distended stomach due to duodenal obstruction by tumor which obstruct the bile duct as well [15].
- Physical Examination findings in malignant obstruction: Jaundice, Stigmata of chronic liver disease, Pruritus, Courvoisier’s law, Troisier’s sign (Virchow’s node), Hepatomegaly, Sister Joseph nodule, Ascites [16].
Imaging Modalities Summary
- Imaging modalities for obstructive jaundice: Ultrasonography, Endoscopic ultrasonography, Endoscopic retrograde cholangiopancreatography (ERCP), Percutaneous transhepatic cholangiography (PTC) and drainage (PTBD), Computed tomography (CT), Magnetic resonance imaging (MRI) and cholangiopancreatography (MRCP), Positron emission tomography (PET) [24].
- Ultrasound/CT: Size of bile duct, Level of obstruction, Cause of obstruction, Other associated features. Malignant disease: staging. Benign disease: gallstones > cx [25].
High Yield Summary — Management of Jaundice
- Management is cause-directed: first determine whether jaundice is pre-hepatic, hepatic, or post-hepatic, then treat the underlying pathology.
- Obstructive jaundice with cholangitis is an emergency: Resuscitation + IV antibiotics + urgent biliary decompression.
- ERCP is first-line for distal obstructive jaundice and choledocholithiasis; PTBD is preferred when ERCP fails, is contraindicated, or the obstruction is proximal/hilar.
- CBD stones: ERCP with sphincterotomy and stone extraction, followed by laparoscopic cholecystectomy.
- Malignant biliary obstruction: resectable disease proceeds to staging and surgery; unresectable disease is managed palliatively with stenting/PTBD, symptom control, and systemic therapy.
- Choledochal cysts require complete excision + Roux-en-Y hepaticojejunostomy because of malignant potential.
- PSC/PBC are primarily medical diseases; liver transplantation is the definitive treatment for end-stage disease.
High Yield Summary — Complications of Jaundice
Complications of jaundice span from acute neurological injury in babies to the insidious consequences of chronic liver disease and the high stakes of cancer and its treatments. Your management plan must always anticipate and try to prevent these complications—whether it's giving Vitamin K, draining an infected biliary system urgently, or providing nutritional support before major surgery.